We are live on ! Find out more
AIC

Argus Investors Counsel Portfolio holdings

AUM $130M
1-Year Est. Return 37.06%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$163M
AUM Growth
+$7.15M
Cap. Flow
-$8.97M
Cap. Flow %
-5.51%
Top 10 Hldgs %
27.73%
Holding
114
New
16
Increased
20
Reduced
66
Closed
6

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.57M
2
ADM icon
Archer Daniels Midland
ADM
+$1.47M
3
UNP icon
Union Pacific
UNP
+$1.43M
4
PYPL icon
PayPal
PYPL
+$1.18M
5
AVGO icon
Broadcom
AVGO
+$865K

Sector Composition

Rank Sector Weight
1 Technology 23.38%
2 Financials 15.18%
3 Healthcare 14.94%
4 Industrials 13%
5 Consumer Discretionary 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
51
Air Products & Chemicals
APD
$68.9B
$1.43M 0.88%
5,885
+440
+8% +$108K
REGN icon
52
Regeneron Pharmaceuticals
REGN
$82.1B
$1.41M 0.87%
+1,465
New +$1.39M
ZTS icon
53
Zoetis
ZTS
$31.1B
$1.4M 0.86%
8,299
-1,465
-15% -$274K
TXN icon
54
Texas Instruments
TXN
$257B
$1.39M 0.85%
7,979
-730
-8% -$122K
WFC icon
55
Wells Fargo
WFC
$264B
$1.35M 0.83%
23,286
-92
-0.4% -$4.81K
IP icon
56
International Paper
IP
$22.1B
$1.34M 0.82%
34,290
-6,100
-15% -$221K
PFE icon
57
Pfizer
PFE
$152B
$1.32M 0.81%
47,440
+4,125
+10% +$114K
CSCO icon
58
Cisco
CSCO
$475B
$1.31M 0.81%
26,339
-3,036
-10% -$151K
NOC icon
59
Northrop Grumman
NOC
$81.8B
$1.3M 0.8%
2,707
-6
-0.2% -$2.76K
ABT icon
60
Abbott
ABT
$190B
$1.27M 0.78%
11,185
-1,100
-9% -$126K
CVX icon
61
Chevron
CVX
$386B
$1.27M 0.78%
8,043
+524
+7% +$79.1K
INTC icon
62
Intel
INTC
$493B
$1.24M 0.76%
28,010
-3,300
-11% -$147K
GLW icon
63
Corning
GLW
$137B
$1.15M 0.71%
35,035
-6,776
-16% -$216K
BDX icon
64
Becton Dickinson
BDX
$49.4B
$1.15M 0.71%
4,660
-900
-16% -$215K
CRM icon
65
Salesforce
CRM
$162B
$1.14M 0.7%
3,777
+46
+1% +$13.3K
MCHP icon
66
Microchip Technology
MCHP
$44B
$1.11M 0.68%
12,348
-4,787
-28% -$413K
IWF icon
67
iShares Russell 1000 Growth ETF
IWF
$127B
$1.04M 0.64%
12,368
-20
-0.2% -$1.61K
MA icon
68
Mastercard
MA
$492B
$1.01M 0.62%
2,096
+251
+14% +$115K
XONE icon
69
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$843M
$954K 0.59%
+19,219
New +$955K
VEA icon
70
Vanguard FTSE Developed Markets ETF
VEA
$236B
$933K 0.57%
+18,590
New +$898K
UNH icon
71
UnitedHealth
UNH
$365B
$876K 0.54%
1,770
+108
+6% +$54.9K
AJG icon
72
Arthur J. Gallagher & Co
AJG
$65B
$762K 0.47%
3,049
+66
+2% +$15.9K
INTU icon
73
Intuit
INTU
$92B
$687K 0.42%
1,058
-12
-1% -$7.66K
CTAS icon
74
Cintas
CTAS
$82.1B
$683K 0.42%
3,976
-48
-1% -$7.39K
KLAC icon
75
KLA
KLAC
$262B
$677K 0.42%
+9,690
New +$622K

Similar funds

Argus Investors Counsel's Q1 2024 Portfolio in Review

As of Q1 2024, Argus Investors Counsel held 114 positions worth $163M, up 4.6% from $156M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Argus Investors Counsel withdrew a net $8.97M in Q1 2024, closing 6 positions and reducing 66 holdings. Its most notable exit was Archer Daniels Midland, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Argus Investors Counsel opened a new position in Regeneron Pharmaceuticals worth $1.41M.

  • Argus Investors Counsel's largest Q1 2024 buy was Regeneron Pharmaceuticals: 1,465 shares worth $1.41M.
  • Argus Investors Counsel added most to Trane Technologies in Q1 2024, an estimated $2.02M increase.
  • Argus Investors Counsel's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $3.57M.
  • Argus Investors Counsel fully exited Archer Daniels Midland in Q1 2024, selling an estimated $1.47M.
  • Argus Investors Counsel's ten largest holdings make up 28% of its $163M portfolio in Q1 2024.
  • Argus Investors Counsel opened 16 new positions and closed 6 in Q1 2024.
  • Argus Investors Counsel's portfolio value rose 4.6% quarter-over-quarter to $163M.

Based on Argus Investors Counsel's 13F filing for Q1 2024, filed 25 Apr 2024.